Revenue

12 Months Ended

Jun. 30, 2019

Revenue from Contract with Customer [Abstract]

Revenue

Revenue

Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales, value add, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.

The Company generates the majority of its revenue through product sales to customers. These products include the Protandim^® line of dietary supplements, LifeVantage^® Omega+ and ProBio dietary supplements, the TrueScience^® line of Nrf2-infused skin and hair care products, Petandim^™ for Dogs, Axio^® Smart Energy Drink mixes, and the PhysIQ^™ Smart Weight Management System. The Company ships most of its product directly to the consumer and receives substantially all payment for product sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. For items sold in packs and bundles, the Company determines the standalone selling price at contract inception for each distinct good, and then allocates the transaction price on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Shipping and handling revenue is recognized upon shipment when the performance obligation is completed.

The Company also charges amounts to independent distributors to attend events held by the Company. Tickets to events are sold as standalone items or included within packs. For event tickets sold in packs, the Company allocates a portion of the transaction price to the ticket on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Fee revenue associated with ticket sales is recorded in the month that the event is held, which is when the Company has performed its obligations under the contract.

Deferred Revenue

The Company records deferred revenue when cash payments are received or due in advance of performance, including amounts which are refundable. Deferred revenue is included in accrued expenses in the condensed consolidated balance sheets and includes pre-sell tickets to events and obligations related to the Company’s loyalty points program. The Company pre-sells tickets to its events. When cash payments are received in advance of events, the cash received is recorded to deferred revenue until the event is held, at which time the Company has performed its obligations under the contract and the revenue is recognized. Historically, the Company has offered a loyalty points program for its customers that allows the customers to earn points from ongoing purchases that can be redeemed for products. As of December 31, 2018, the Company discontinued its

loyalty points program and all revenue previously deferred under the program has been recognized. The Company accounted for these points prior to the discontinuance of the program as a reduction to the transaction price based on estimated usage.

Sales Returns and Allowances

Estimated returns are recorded when product is shipped. Subject to some exceptions based on local regulations, the Company’s return policy is to provide a full refund for product returned within 30 days, if the returned product is unopened or defective. After 30 days, the Company generally does not issue refunds to direct sales customers for returned product. The Company allows terminating independent distributors to return up to 30% of unopened, unexpired product that they have purchased within the prior twelve months for a full refund, less a 10% restocking fee. The Company establishes a refund liability reserve and an asset reserve for its right to recover products based on historical experience. The returns asset reserve and returns liability reserve are evaluated on a quarterly basis. As of June 30, 2019 and 2018, the Company’s return liability reserve, net was $0.4 million and $0.4 million, respectively.

Geographic Information

The Company reports revenue in two geographic regions: the Americas region and the Asia/Pacific & Europe region. The following table presents the Company's revenue disaggregated by these two geographic regions (in thousands):

	Years ended June 30,
	2019		2018		2017
Americas	$	163,236	$	151,609	$	150,841
Asia/Pacific & Europe	62,722		51,595		48,648
Total revenue	$	225,958	$	203,204	$	199,489

Additional information as to the Company’s revenue from operations in the most significant geographical areas is set forth below (in thousands):

	Years ended June 30,
	2019		2018		2017
United States	$	151,966	$	142,452	$	144,842
Japan	$	40,796	$	41,843	$	39,390

Major Products

The Company's revenue is largely attributed to two product lines, Protandim^® and TrueScience^®, which each accounted for more than 10% of total revenue for each of the fiscal years ended June 30, 2018 and 2017. For the fiscal year ended June 30, 2019, Protandim^® was the only product line that accounted for more than 10% of total revenue. On a combined basis, these products represent approximately 78.0%, 76.6% and 77.9% of the Company's total revenue for the fiscal years ended June 30, 2019, 2018 and 2017, respectively. The following table shows revenue by major product line for the fiscal years ended June 30, 2019, 2018 and 2017.

	Years ended June 30,
	2019				2018				2017
Protandim® product line	$	155,499	68.8	%	$	133,923	65.9	%	$	130,873	65.6	%
TrueScience® product line	20,881		9.2	%	21,665		10.7	%	24,440		12.3	%
Other	49,578		22.0	%	47,616		23.4	%	44,176		22.1	%
Total	$	225,958	100.0	%	$	203,204	100.0	%	$	199,489	100.0	%